Night-time use of rotigotine in advanced Parkinson's disease

Functional Neurology

Volumn 25, Issue 4, 2010, Pages 201-203

  Canesi, Margherita ^a   Mariani, Claudio B ^a   Isaias, Ioannis U ^b   Pezzoli, Gianni ^a  

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Parkinson's disease; Rotigotine; Sleep disorders

Indexed keywords

APOMORPHINE; LEVODOPA; ROTIGOTINE;

ADULT; AGED; APPLICATION SITE IRRITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; EVENING DOSAGE; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PILOT STUDY; SLEEP DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; APOMORPHINE; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS; SLEEP DISORDERS; TETRAHYDRONAPHTHALENES; THIOPHENES; TREATMENT OUTCOME;

EID: 79952794507     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Barone P, Antonini A, Colosimo C et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24:1641-1649
2. Barone P, Amboni M, Vitale C, Bonavita V. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 2004;63:S35-S38 (Pubitemid 39426259)
3. Pahwa R, Busenbark K, Huber SJ, Michalek D, Hubble JP, Koller WC. Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease. Neurology 1993;43:677-681 (Pubitemid 23121955)
4. Pastor P, Tolosa E. Cabergoline in the treatment of Parkinson's disease. Neurologia 2003;18:202-209 (Pubitemid 36934747)
5. Chaudhuri KR. Noctural symptom complex in PD and its managemenet. Neurology 2003;61:S17-S23 (Pubitemid 37151642)
6. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356:39-46 (Pubitemid 46041752)
7. Reuter I, Ellis CM, Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's diseases and restless legs syndrome. Acta Neurol Scand 1999;100:163-167 (Pubitemid 29376827)
8. Bunten S, Happe S. Rotigotine transdermal system: a short review Neuropsychiatr Dis Treat 2006;2:421-426
9. Chen JJ, Swope DM, Dashtipour K, Lyons KE. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease. Pharmacotherapy 2009;29:1452-1467
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184
11. Chaudhuri KR, Pal S, DiMarco A et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-635 (Pubitemid 35448845)
12. Trenkwalder C, Kies B, Rudzinska M et al. Rotigotine effects on early morning motor function and sleep in Parkinson's Disease: a double-blind, randomized, placebo-controlled study (RECOVER) Mov Disord 2010 Nov 18 [Epub ahead of print]
13. Antonini A, Bernardi L, Calandrella D, Mancini F, Plebani M. Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders. Funct Neurol 2010;25:21-25